Safety of green LED phototherapy for neonatal hyperbilirubinemia: A randomized controlled trial
Pediatrics International · 2025-01 · 67 (1)
DOI: 10.1111/ped.70289 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Pediatrics International, online erschienen am 12.12.2025. Verfasst von Takaaki Sadamura und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neonatology, National Hospital Organization Shikoku Medical Center for Children and Adults, Zentsuji, Japan. Hauptthemen laut MEDLINE: Hyperbilirubinemia, Neonatal, Phototherapy. Die Arbeit nennt 21 Literaturangaben. Gefördert von: Shikoku Medical Center for Children and Adults.
Abstract (Originalsprache)
Background
Green light‐emitting diodes (LEDs) are still not widely used worldwide for neonatal hyperbilirubinemia, likely because their irradiance has not been properly evaluated and reports on their safety are scarce. We compared safety between green and blue LED phototherapy for the treatment of neonatal hyperbilirubinemia by using the alkaline comet assay method.
Methods
This randomized controlled trial included 40 neonates with neonatal hyperbilirubinemia who were randomly allocated to green and blue LED phototherapy groups. Blood samples were obtained before and after 24 h of phototherapy in both groups. DNA damage was evaluated by alkaline comet assay. Total serum bilirubin (TSB) was measured using enzymatic methods.
Results
The increases in % tail DNA after 24 h of phototherapy were not significantly different between the two groups. The TSB reduction was significantly greater in the green LED group than in the blue LED group ( p < 0.01).
Conclusion
Green LED phototherapy appears to be reasonably safe in terms of DNA damage and shows a slightly greater effect in reducing serum bilirubin levels compared with blue LED phototherapy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neonatology, National Hospital Organization Shikoku Medical Center for Children and Adults, Zentsuji, Japan.
- Department of Pediatrics, Faculty of Medicine, Kagawa University, Miki-cho, Japan.
- Department of Medical Technology, Kagawa Prefectural University of Health Science, Takamatsu, Japan.
ORCID-Profile: Toru Kuboi, Takashi Kusaka
Förderung
- Shikoku Medical Center for Children and Adults
Zitieren
APA
Sadamura, T., Kuboi, T., Noguchi, Y., Tadatomo, Y., Takada, K., Kawaguchi, N., Sugino, M., Nakano, A., Koyano, K., Nakamura, S., Yasuda, S., Okada, H., Itoh, S., & Kusaka, T. (2025). Safety of green LED phototherapy for neonatal hyperbilirubinemia: A randomized controlled trial. Pediatrics International, 67(1). https://doi.org/10.1111/ped.70289
Vancouver
Sadamura T, Kuboi T, Noguchi Y, Tadatomo Y, Takada K, Kawaguchi N, et al. Safety of green LED phototherapy for neonatal hyperbilirubinemia: A randomized controlled trial. Pediatrics International. 2025;67(1). doi:10.1111/ped.70289
BibTeX
@article{Sadamura2025,
author = {Sadamura, Takaaki and Kuboi, Toru and Noguchi, Yuta and Tadatomo, Yoko and Takada, Kousei and Kawaguchi, Nana and Sugino, Masashiro and Nakano, Akiko and Koyano, Kosuke and Nakamura, Shinji and Yasuda, Saneyuki and Okada, Hitoshi and Itoh, Susumu and Kusaka, Takashi},
title = {Safety of green LED phototherapy for neonatal hyperbilirubinemia: A randomized controlled trial},
journal = {Pediatrics International},
year = {2025},
volume = {67},
number = {1},
doi = {10.1111/ped.70289}
}
EUVIMED